Previous studies have shown that C1q is the first recognition subcomponent of the complement classical pathway, which is comprised of three chains: C1qA, C1qB, and C1qC, and plays complex effects in the occurrence of various tumors, such as prostate cancer 41, ovarian cancer 42 and gliomas 43. Here, C1QC is linked to prostate carcinoma.